Breast conserving surgery and radiation as a choice for patients with BRCA mutations

Christine Alves Pinto, Katherine Kotinsley, Mark Gerard Trombetta

Abstract


Patients who are diagnosed with early stage breast cancer and who test positive for the BRCA1 and/or BRCA2 genetic mutations have been considered better candidates for bilateral mastectomy (ipsilateral therapeutic and contralateral prophylactic) as an accepted standard of care as compared to breast conserving surgery. Recently the increasing evidence that mastectomy may not be required has prompted us to review the literature and develop evidence-based recommendations in order to allow patients the option of mastectomy avoidance as long as they are well-informed and agreeable to close surveillance.



Full Text: PDF DOI: 10.5430/jst.v2n5p45

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press


To make sure that you can receive messages from us, please add the 'Sciedu.ca' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.